Stem cell-derived neurotrophic support for the neuromuscular junction in spinal muscular atrophy

Abstract

Importance of the field: Spinal muscular atrophy (SMA) is a neurodegenerative disease characterized by specific degeneration of α-motor neurons in the spinal cord. The use of cell transplantation to restore lost function through cell replacement or prevent further degeneration of motor neurons and synapses through neurotrophic support heralds tremendous hope in the SMA field.

Areas covered in this review: Much research has been carried out in the last decade on the use of embryonic stem cells in cell replacement strategies for various neurodegenerative diseases. Cell replacement is contingent on the ability of transplanted cells to integrate and form new functional connections with host cells. In the case of SMA, cell replacement is a tall order in that axons of transplanted cells would be required to grow over long distances from the spinal cord through growth-averse terrain to synapse with muscles in the periphery. The efficacy of neurotrophic support is contingent on the ability of transplanted cells to secrete neurotrophins appropriate for degenerating motor neurons in the spinal cord or development/stability of the neuromuscular junction (NMJ) in the periphery.

What the reader will gain: The reader will gain an understanding of the potential of neurotrophins to promote development of the NMJ in a diseased or injured environment.

Take home message: Neurotrophins play a major role in NMJ development and thus may be a key factor in the pathogenesis of NMJs in SMA. Further research into the signaling mechanisms involved in NMJ maturation may identify additional mechanisms by which transplanted cells may be of therapeutic benefit.

Keywords::

• acetylcholine receptor
• embryonic stem cells
• motor neurons
• neuromuscular junction
• neurotrophins
• spinal muscular atrophy
• subunit switching

Notes

This box summarizes key points contained in the article.